For research use only. Not for therapeutic Use.
GnRH antagonist 2 (formula I) is a GnRH receptor antagonist that can be used for endometriosis research[1].
Catalog Number | I044535 |
CAS Number | 1709823-61-9 |
Synonyms | 1-[4-[7-[(2,6-difluorophenyl)methyl]-3-[(dimethylamino)methyl]-5-(6-methoxypyridazin-3-yl)-4,6-dioxopyrazolo[3,4-d]pyrimidin-2-yl]phenyl]-3-methoxyurea |
Molecular Formula | C28H27F2N9O5 |
Purity | ≥95% |
InChI | InChI=1S/C28H27F2N9O5/c1-36(2)15-21-24-25(34-39(21)17-10-8-16(9-11-17)31-27(41)35-44-4)37(14-18-19(29)6-5-7-20(18)30)28(42)38(26(24)40)22-12-13-23(43-3)33-32-22/h5-13H,14-15H2,1-4H3,(H2,31,35,41) |
InChIKey | IMJPTZZFUZNJLV-UHFFFAOYSA-N |
SMILES | CN(C)CC1=C2C(=NN1C3=CC=C(C=C3)NC(=O)NOC)N(C(=O)N(C2=O)C4=NN=C(C=C4)OC)CC5=C(C=CC=C5F)F |
Reference | [1]. Quanliang Zhang, et al. Crystalline form of gnrh receptor antagonist and preparation method therefor. WO2018086608A1. |